CFS
VNDA icon

CGC Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

CGC Financial Services’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$246 Hold
50
– – ﹤0.01% 331
2026
Q2 		$306 Hold
50
– – ﹤0.01% 327
2026
Q1 		$346 Hold
50
– – ﹤0.01% 320
2025
Q4 		$441 Hold
50
– – ﹤0.01% 323
2025
Q3 		$250 Hold
50
– – ﹤0.01% 331
2025
Q2 		$236 Hold
50
– – ﹤0.01% 321
2025
Q1 		$230 Hold
50
– – ﹤0.01% 319
2024
Q4 		$240 Hold
50
– – ﹤0.01% 330
2024
Q3 		$235 Hold
50
– – ﹤0.01% 328
2024
Q2 		$283 Hold
50
– – ﹤0.01% 328
2024
Q1 		$206 Hold
50
– – ﹤0.01% 341
2023
Q4 		$211 Hold
50
– – ﹤0.01% 354
2023
Q3 		$216 Hold
50
– – ﹤0.01% 314
2023
Q2 		$330 Buy
+50
New +$321 ﹤0.01% 333

Other funds holding VNDA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CGC Financial Services's VNDA Position: Q3 2026 in Review

CGC Financial Services held its Vanda Pharmaceuticals (VNDA) position steady in Q3 2026 at 50 shares worth $246. The position accounts for ﹤0.01% of the portfolio, ranked #331.

CGC Financial Services first reported a position in VNDA in Q2 2023 and has held it in 14 quarters since. The position peaked at $441 in Q4 2025. 9 funds tracked by Wall St. Rank hold VNDA as of Q3 2026.

  • CGC Financial Services held 50 shares of Vanda Pharmaceuticals worth $246 as of Q3 2026.
  • CGC Financial Services left its Vanda Pharmaceuticals share count unchanged in Q3 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of CGC Financial Services's portfolio in Q3 2026, its #331 holding.
  • CGC Financial Services first reported a position in Vanda Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • CGC Financial Services's Vanda Pharmaceuticals position peaked at $441 in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2026.

Based on CGC Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.